Allergies Bacteria Doctors FDA Approval 
The Pharma Data
JULY 29, 2021
BOTOX ® was first approved by the FDA in 1989 for two rare eye muscle disorders – blepharospasm and strabismus in adults. Tell your doctor if you have any breathing-related problems. Tell your doctor if you have any breathing-related problems. About BOTOX ®. Cornea problems have been reported. versus 0.4%, respectively).
The Pharma Data
SEPTEMBER 10, 2021
About BOTOX ® BOTOX ® was first approved by the FDA in 1989 for two rare eye muscle disorders – blepharospasm and strabismus in adults. Tell your doctor if you have any breathing-related problems. Tell your doctor if you have any breathing-related problems. Cornea problems have been reported. versus 0.4%, respectively).
The Pharma Data
SEPTEMBER 8, 2021
About BOTOX ® BOTOX ® was first approved by the FDA in 1989 for two rare eye muscle disorders – blepharospasm and strabismus in adults. Tell your doctor if you have any breathing-related problems. Tell your doctor if you have any breathing-related problems. Atogepant is currently under review by the U.S.
Expert insights. Personalized for you.
52 
Let's personalize your content